India Drug Delivery Devices Market by Route of Administration (Topical, Injectable, Ocular, and Others), Applications (Infectious diseases, Cardiovascular cancer, Diabetes, and Others), and End-users (Ambulatory Surgical Centres, Hospitals, and Others), and Country–Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028
The India drug delivery devices market size is expected to expand at significant CAGR during the forecast period, 2021–2028. Growth of the market is attributed to the increasing funding from government & private organization, rising number of development & research activities, rise in technological advancement, and unhealthy lifestyle.
The delivery of a drug and therapeutic is done by specialized tools from a specific route of administration like drug delivery devices. As part of one & more medical treatments such devices are used.
The Covid-19 pandemic affected the demand and supply of India drug delivery devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Market Trends, Drivers, Restraints, and Opportunities
- Technological advancement in device sector is projected to boost the market in the coming years.
- Increasing number of diseases requiring drug delivery is the major factor fueling the market.
- Rising risk of needlestick injuries is anticipated to restrict the market growth.
- Lack of awareness about drug delivery devices present a main challenge that can hamper the market expansion during the forecast period.
- R&D investment and technological advancement drug delivery devices market is projected to offer lucrative opportunities for the market players.
Scope of the Report
The report on the India drug delivery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
India Drug Delivery Devices Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018-2019 |
|
Forecast Period |
2021-2028 |
|
Segmentation |
Route of Administration (Topical, Injectable, Ocular, and Others), Applications (Infectious diseases, Cardiovascular cancer, Diabetes, and Others), and End-users (Ambulatory Surgical Centres, Hospitals, and Others) |
|
Country |
India |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players covered in the Report |
Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi |
Market Segment Insights
The topical segment accounts for key share of the market
Based on route of administration, the India drug delivery devices market is divided into topical, injectable, ocular, and others. The topical segment accounts for a key share of the market. Growth of the market is attributed to the rising prevalence of cardiac disease, unhealthy lifestyles, rise in elderly population, and increasing number of treatments. However, the injectable segment is anticipated to expand at a rapid pace during the forecast period due to increasing patient pool and increasing preference for minor invasive surgeries.
The diabetes segment is anticipated to hold major market share during the forecast period
Based on applications, the market is fragmented into infectious diseases, cardiovascular cancer, diabetes, and others. The diabetes segment is anticipated to hold the major market share during the forecast period. Growth of the market is attributed to rising population, increasing disposable income, and growing awareness among population. However, the infectious diseases segment is anticipated to expand at a rapid pace during the forecast period due to factors such as international companies attracting many investors, technological innovations in drug delivery devices, and increasing adaptation of stem cell technologies.
The hospitals segment accounts for a key share of the market
On the basis of end-users, the India drug delivery devices market is segmented into ambulatory surgical centres, hospitals, and others. The hospitals segment accounts for a key share of the market. Growth of the market is attributed to penetration of drug delivery devices in market and increasing per capita income. However, the ambulatory surgical centres segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing funding from private organizations.
Market outlook
The India drug delivery devices market is anticipated to expand at a high CAGR during the forecast period due to increasing demand for drug delivery devices and rising awareness about health. Growth of the market is attributed to introduction of technological and novel advanced product and smart drug delivery devices for diseases management.
Rapid development in the health sector increased the demand for drug delivery devices in the India. Increasing number of fatal diseases due to changing life style among people is the major factor fueling the market during the forecast period.
Segments
Segments Covered in the Report
The India drug delivery devices market has been segmented on the basis of
Route of Administration
- Topical
- Injectable
- Ocular
- Others
Applications
- Infectious diseases
- Cardiovascular cancer
- Diabetes
- Others
End-users
- Ambulatory Surgical Centres
- Hospitals
- Others
Country
- India
Key Players
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- 3M Company
- Merck & Co.
- GlaxoSmithKline PLC
- Bayer AG
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- Novartis AG
- Sarofi
Competitive Landscape
Key players competing in the India drug delivery devices market include Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi
Some of these players are using several market strategies such as product launches, partnerships, merger, capacity expansion, collaborations, and acquisitions to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Delivery Devices Market - Supply Chain
4.5. Global Drug Delivery Devices Market Forecast
4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Drug Delivery Devices Market Size and Volume Forecast by Applications
5.3.1. Infectious diseases
5.3.2. Cardiovascular cancer
5.3.3. Diabetes
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Drug Delivery Devices Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Drug Delivery Devices Market Size and Volume Forecast by End Users
6.3.1. Ambulatory Surgical Centres
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Drug Delivery Devices Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Drug Delivery Devices Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
8. North America Drug Delivery Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Drug Delivery Devices Market Size and Volume Forecast by Applications
8.4.1. Infectious diseases
8.4.2. Cardiovascular cancer
8.4.3. Diabetes
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Drug Delivery Devices Market Size and Volume Forecast by End Users
8.7.1. Ambulatory Surgical Centres
8.7.2. Hospitals
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Latin America Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Applications
9.4.1. Infectious diseases
9.4.2. Cardiovascular cancer
9.4.3. Diabetes
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by End Users
9.7.1. Ambulatory Surgical Centres
9.7.2. Hospitals
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Europe Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Applications
10.4.1. Infectious diseases
10.4.2. Cardiovascular cancer
10.4.3. Diabetes
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Drug Delivery Devices Market Size and Volume Forecast by End Users
10.7.1. Ambulatory Surgical Centres
10.7.2. Hospitals
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Applications
11.4.1. Infectious diseases
11.4.2. Cardiovascular cancer
11.4.3. Diabetes
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by End Users
11.7.1. Ambulatory Surgical Centres
11.7.2. Hospitals
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Applications
12.4.1. Infectious diseases
12.4.2. Cardiovascular cancer
12.4.3. Diabetes
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by End Users
12.7.1. Ambulatory Surgical Centres
12.7.2. Hospitals
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Drug Delivery Devices Market: Market Share Analysis
13.2. Drug Delivery Devices Distributors and Customers
13.3. Drug Delivery Devices Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Sun Pharmaceutical Industries Ltd.
13.4.2. Pfizer Inc.
13.4.3. 3M Company
13.4.4. Merck & Co.
13.4.5. GlaxoSmithKline PLC
13.4.6. Bayer AG
13.4.7. F. Hoffmann-La Roche AG
13.4.8. Johnson
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Delivery Devices Market - Supply Chain
4.5. Global Drug Delivery Devices Market Forecast
4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Drug Delivery Devices Market Size and Volume Forecast by Applications
5.3.1. Infectious diseases
5.3.2. Cardiovascular cancer
5.3.3. Diabetes
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Drug Delivery Devices Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Drug Delivery Devices Market Size and Volume Forecast by End Users
6.3.1. Ambulatory Surgical Centres
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Drug Delivery Devices Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Drug Delivery Devices Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
8. North America Drug Delivery Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Drug Delivery Devices Market Size and Volume Forecast by Applications
8.4.1. Infectious diseases
8.4.2. Cardiovascular cancer
8.4.3. Diabetes
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Drug Delivery Devices Market Size and Volume Forecast by End Users
8.7.1. Ambulatory Surgical Centres
8.7.2. Hospitals
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Latin America Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Applications
9.4.1. Infectious diseases
9.4.2. Cardiovascular cancer
9.4.3. Diabetes
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by End Users
9.7.1. Ambulatory Surgical Centres
9.7.2. Hospitals
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Europe Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Applications
10.4.1. Infectious diseases
10.4.2. Cardiovascular cancer
10.4.3. Diabetes
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Drug Delivery Devices Market Size and Volume Forecast by End Users
10.7.1. Ambulatory Surgical Centres
10.7.2. Hospitals
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Applications
11.4.1. Infectious diseases
11.4.2. Cardiovascular cancer
11.4.3. Diabetes
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by End Users
11.7.1. Ambulatory Surgical Centres
11.7.2. Hospitals
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Applications
12.4.1. Infectious diseases
12.4.2. Cardiovascular cancer
12.4.3. Diabetes
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by End Users
12.7.1. Ambulatory Surgical Centres
12.7.2. Hospitals
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Drug Delivery Devices Market: Market Share Analysis
13.2. Drug Delivery Devices Distributors and Customers
13.3. Drug Delivery Devices Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Sun Pharmaceutical Industries Ltd.
13.4.2. Pfizer Inc.
13.4.3. 3M Company
13.4.4. Merck & Co.
13.4.5. GlaxoSmithKline PLC
13.4.6. Bayer AG
13.4.7. F. Hoffmann-La Roche AG
13.4.8. Johnson
Segments Covered in the Report
The India drug delivery devices market has been segmented on the basis of
Route of Administration
- Topical
- Injectable
- Ocular
- Others
Applications
- Infectious diseases
- Cardiovascular cancer
- Diabetes
- Others
End-users
- Ambulatory Surgical Centres
- Hospitals
- Others
Country
- India
Key Players
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- 3M Company
- Merck & Co.
- GlaxoSmithKline PLC
- Bayer AG
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- Novartis AG
- Sarofi
Key players competing in the India drug delivery devices market include Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi
Some of these players are using several market strategies such as product launches, partnerships, merger, capacity expansion, collaborations, and acquisitions to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
Our Clients
Related Reports
Some other reports from this category!
